Shares of 111 Inc – (NASDAQ:YI) have earned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.

Brokers have set a 12-month consensus price objective of $14.00 for the company, according to Zacks. Zacks has also assigned 111 an industry rank of 97 out of 256 based on the ratings given to its competitors.

NASDAQ:YI traded up $1.91 on Tuesday, hitting $4.99. The stock had a trading volume of 1,868,454 shares, compared to its average volume of 40,672. 111 has a 52-week low of $2.29 and a 52-week high of $16.83. The stock has a market cap of $187.55 million and a price-to-earnings ratio of -4.50. The business’s 50-day simple moving average is $3.14 and its two-hundred day simple moving average is $6.20.

111 (NASDAQ:YI) last issued its quarterly earnings results on Thursday, August 15th. The company reported ($0.18) EPS for the quarter. The company had revenue of $122.09 million during the quarter. 111 had a negative return on equity of 39.18% and a negative net margin of 18.45%. Equities analysts forecast that 111 will post -1.32 EPS for the current fiscal year.

111 Company Profile

111, Inc, through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers.

Further Reading: Why is momentum important to successful trading?

Get a free copy of the Zacks research report on 111 (YI)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with's FREE daily email newsletter.